dementia

Raised GFAP concentrations appear to be unique to GRN-related FTD, with levels potentially increasing just prior to symptom onset, suggesting that GFAP may be an important marker of proximity to onset, and helpful for forthcoming therapeutic prevention trials

In this study, our results suggest that amyloid deposition in FTD patients may be associated with a higher mortality.

An educative case report on a carbon-monoxide delayed encephalopathy.